These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8281243)

  • 1. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.
    Beasley CM; Holman SL; Potvin JH
    Ann Clin Psychiatry; 1993 Sep; 5(3):199-207. PubMed ID: 8281243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study of fluoxetine and imipramine in major depression.
    Bressa GM; Brugnoli R; Pancheri P
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():69-73. PubMed ID: 2783701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.
    Beasley CM; Sayler ME; Bosomworth JC; Wernicke JF
    J Clin Psychopharmacol; 1991 Jun; 11(3):166-74. PubMed ID: 2066455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    Cohn JB; Collins G; Ashbrook E; Wernicke JF
    Int Clin Psychopharmacol; 1989 Oct; 4(4):313-22. PubMed ID: 2607128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose.
    Beasley CM; Nilsson ME; Koke SC; Gonzales JS
    J Clin Psychiatry; 2000 Oct; 61(10):722-8. PubMed ID: 11078032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.
    Beasley CM; Sayler ME; Potvin JH
    Int Clin Psychopharmacol; 1993; 8(3):143-9. PubMed ID: 8263311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine.
    Tollefson GD; Greist JH; Jefferson JW; Heiligenstein JH; Sayler ME; Tollefson SL; Koback K
    J Clin Psychopharmacol; 1994 Dec; 14(6):385-91. PubMed ID: 7884018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of a new antidepressant, fluoxetine.
    Levine S; Deo R; Mahadevan K
    Br J Psychiatry; 1987 May; 150():653-5. PubMed ID: 3307982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW; Hamilton SH; Bystritsky A; Meyers BS; Nemeroff CB
    Int Psychogeriatr; 1995; 7 Suppl():41-53. PubMed ID: 8580391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacotherapy of minor depression.
    Stewart JW; Quitkin FM; Klein DF
    Am J Psychother; 1992 Jan; 46(1):23-36. PubMed ID: 1543251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
    Beasley CM; Koke SC; Nilsson ME; Gonzales JS
    Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.